Invesco »

Prelude Therapeutics shares owned by Invesco

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Invesco from 13F filings

Historical chart of Invesco investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Invesco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Invesco

Quarter filed Position value Share count Share price at filing
2026-06-30 $185k 35k 5.33

More positions owned by Invesco

NVIDIA Corporation (NVDA)
Apple (AAPL)
Micron Technology (MU)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Advanced Micro Devices (AMD)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Lam Research Corp Com New (LRCX)
Intel Corporation (INTC)
Meta Platforms Cl A (META)
Applied Materials (AMAT)
Wal-Mart Stores (WMT)

View all positions for Invesco

Top funds holding Prelude Therapeutics

OrbiMed Advisors
Baker Bros. Advisors
RA Capital Management
Soleus Capital Management
Kynam Capital Management
Vanguard Capital Management
BlackRock
Sphera Funds Management
Two Sigma Investments
ADAR1 Capital Management
Millennium Management
Geode Capital Management
Adage Capital Partners GP
Acadian Asset Management
Morgan Stanley

View all funds holding Prelude Therapeutics